I am a Biologist graduated from National Autonomous University of Mexico, where I also obtained my Master’s and Ph.D. degrees in Biological Sciences. I currently work as a Postdoctoral Researcher at Autonomous University of Mexico City, developing research projects focused on oncogenomics, epigenetics, and tumor metabolism.
My scientific career has focused on the study of molecular mechanisms involved in breast cancer, obesity, cell signaling, and epigenetic regulation. During my doctoral studies, under the supervision of Alejandro Zentella, I investigated the effects of metformin on the PI3K/Akt and NF-kB signaling pathways in women with obesity and breast cancer, identifying patient subgroups with potential therapeutic benefit associated with metformin treatment. I later completed a postdoctoral fellowship at the Genomics Laboratory of National Cancer Institute of Mexico, studying the role of lncRNAs in tumor metabolism regulation.
My research interests include cancer biology, tumor metabolism, obesity, epigenetics, cell signaling, and non-coding RNA-mediated gene regulation. My work focuses on understanding how the tumor microenvironment and obesity-associated metabolic alterations contribute to transcriptional and epigenetic reprogramming in cancer cells, as well as mechanisms associated with proliferation, migration, invasion, and therapeutic resistance.
I am a Biologist graduated from National Autonomous University of Mexico, where I also obtained my Master’s and Ph.D. degrees in Biological Sciences. I currently work as a Postdoctoral Researcher at Autonomous University of Mexico City, developing research projects focused on oncogenomics, epigenetics, and tumor metabolism.
My scientific career has focused on the study of molecular mechanisms involved in breast cancer, obesity, cell signaling, and epigenetic regulation. During my doctoral studies, under the supervision of Alejandro Zentella, I investigated the effects of metformin on the PI3K/Akt and NF-kB signaling pathways in women with obesity and breast cancer, identifying patient subgroups with potential therapeutic benefit associated with metformin treatment. I later completed a postdoctoral fellowship at the Genomics Laboratory of National Cancer Institute of Mexico, studying the role of lncRNAs in tumor metabolism regulation.
My research interests include cancer biology, tumor metabolism, obesity, epigenetics, cell signaling, and non-coding RNA-mediated gene regulation. My work focuses on understanding how the tumor microenvironment and obesity-associated metabolic alterations contribute to transcriptional and epigenetic reprogramming in cancer cells, as well as mechanisms associated with proliferation, migration, invasion, and therapeutic resistance.